Charles Schwab Investment Management Inc. Cuts Stock Position in 10x Genomics, Inc. (NASDAQ:TXG)
Charles Schwab Investment Management Inc. lessened its stake in 10x Genomics, Inc. (NASDAQ:TXG – Free Report) by 17.2% in the ...
10x Genomics: Lower Cost Innovation May Drive A Rebound
Buy 10x Genomics with a 1-year target of $12.7, projecting 18% growth. Read here for more on TXG stock's biopharma potential ...
Seeking Alpha4d
TXG 10x Genomics, Inc.
10x Genomics, Inc., a life science technology ... and the Asia Pacific. It offers Chromium platform that enables analysis of individual biological components, as well as includes microfluidic ...
Science Daily6d
Solar System News
Mar. 17, 2025 — The James Webb Space Telescope has captured its first direct images of carbon dioxide in a planet outside the solar system in HR 8799, a multiplanet system 130 light-years away ...
Yahoo Finance3d
10x Genomics, Inc. (TXG)
After hours: March 21 at 7:53:55 PM EDT Loading Chart for TXG ...
The EMBO Journal3d
DNA methylation changes during acute COVID-19 are associated with long-term transcriptional dysregulation in patients’ airway epithelial cells
Peer ReviewDownload a summary of the editorial decision process including editorial decision letters, reviewer comments and author responses to feedback. Concurrent analysis of whole-genome DNA ...